News

New malaria vaccine shows promise

BMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7183.557 (Published 27 February 1999) Cite this as: BMJ 1999;318:557
  1. Deborah Josefson,
  2. San Francisco

    An experimental malaria vaccine designed to protect the host from each stage of the parasite's life cycle has shown promise in animal trials (Proceedings of the National Academy of Sciences 1999;96:1615-20).

    Researchers from the US Centers for Disease Control and Prevention in Atlanta, Georgia, have created a recombinant, multivalent vaccine against Plasmodium falciparum, the deadliest malaria parasite. This vaccine differs from previous vaccines because it …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe